Funder
Bill and Melinda Gates Foundation
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference40 articles.
1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022
2. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape;Mazur;Lancet Infect Dis,2022
3. Mathematical modelling of respiratory syncytial virus (RSV) in low-and middle-income countries: a systematic review;Mezei;Epidemics,2021
4. Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study;Li;Lancet Infect Dis,2021
5. Giersing BK, Karron RA, Vekemans J, Kaslow DC, Moorthy VS. Meeting report: Who consultation on respiratory syncytial virus (RSV) vaccine development, Geneva, 25–26 April 2016. Vaccine 2019;37(50):7355–62.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献